1-Methyl-9H-pyrido[3,4-b]indole-3-carboxylic acid

Catalog No.: 
ACWHSC107
CAS No.: 
22329-38-0
Molecular Formula: 
C13H10N2O2
Molecular Weight: 
226.24
1-Methyl-9H-pyrido[3,4-b]indole-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$135.00In stockIn stock
250mg98%$228.00In stockIn stock
1g98%$613.00In stockInquiry
5g98%$2549.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-9H-pyrido[3,4-b]indole-3-carboxylic acid
IUPAC Name1-methyl-9H-pyrido[3,4-b]indole-3-carboxylic acid
MDL No.MFCD00436515
Molecular FormulaC13H10N2O2
Molecular Weight226.24
SMILESO=C(C1=CC2=C(C(C)=N1)NC3=C2C=CC=C3)O
InChI KeyMFEZJNMQTQMDRQ-UHFFFAOYSA-N
Synonym1-methyl-beta-carboline-3-carboxylic acid;1-Methyl-9H-pyrido[3,4-b]indole-3-carboxylic acid;Harman-3-carboxylic acid;9H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-methyl-
CAS No.22329-38-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWHSC107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXAEU530 route compound structure diagram
    ACXAEU53016641-82-0In Stock
  2. Then
  3. ACWHSC107 route product structure diagram
    ACWHSC10722329-38-0In Stock
Inquiry

2. ACWHSC107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHSC107 route product structure diagram
    ACWHSC10722329-38-0In Stock
Inquiry

3. ACWHSC107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHSC107 route product structure diagram
    ACWHSC10722329-38-0In Stock
Inquiry

Comments (0)